Syncromune, Inc. – Trademark Portfolio
Entity Type: 03
Syncromune, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 3 are pending. Notable registered marks include SYNCROVAX, SYNCROMUNE, CANCER THERAPY POWERED BY YOU, and SYNCHRONIZING THE POWER OF IMMUNOTHERAPY. The owner is based in Fort Lauderdale, FL.
2919 East Commercial Blvd.
Fort Lauderdale, FL 33308
Showing of trademarks Trademarks
Trademark Classifications
Syncromune, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Syncromune, Inc. have?
Syncromune, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending, 2 abandoned.
What trademark classes does Syncromune, Inc. file in?
Syncromune, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Syncromune, Inc.'s most well-known trademarks?
Syncromune, Inc.'s registered trademark portfolio includes well-known marks such as SYNCROVAX, SYNCROMUNE, CANCER THERAPY POWERED BY YOU, and SYNCHRONIZING THE POWER OF IMMUNOTHERAPY. These are among 4 currently registered trademarks in the portfolio.
What is Syncromune, Inc.'s trademark registration success rate?
Syncromune, Inc. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 3 applications are pending review.